Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery

NCT00845364 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

290

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Reperfusion Injury
Cardiac Output, Low

Interventions

DRUG: Perhexiline
DRUG: Placebo marked PEXSIG

Sponsor

University Hospital Birmingham

Collaborators

[object Object]
[object Object]
[object Object]